Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled study of aspirin + pseudoephedrine versus single components for sore throat and nasal congestion
2005-001720-36Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aspirin and pseudoephedrine in nasopharyngitis (4 arms), sponsored by Bayer. Primary endpoints: Nasal congestion AUC over 2 hours and Sore throat pain SPID over 2 hours. Started Aug 2006; status: completed.
02
Drugs
aspirinpseudoephedrine
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on 2005-001720-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001720-36.